| Patent | Date |
|---|
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220306721 - SCHUSTER; Heiko ; et al. | 2022-09-29 |
Immunotherapy Against Several Tumors Including Lung Cancer
App 20220298207 - WEINSCHENK; Toni ; et al. | 2022-09-22 |
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220289817 - SCHUSTER; Heiko ; et al. | 2022-09-15 |
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220289816 - SCHUSTER; Heiko ; et al. | 2022-09-15 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,440,947 - Mahr , et al. September 13, 2 | 2022-09-13 |
Immunotherapy Against Several Tumors Including Lung Cancer
App 20220281917 - WEINSCHENK; Toni ; et al. | 2022-09-08 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220280622 - MAHR; Andrea ; et al. | 2022-09-08 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220280623 - MAHR; Andrea ; et al. | 2022-09-08 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,434,274 - Mahr , et al. September 6, 2 | 2022-09-06 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,434,273 - Mahr , et al. September 6, 2 | 2022-09-06 |
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
Grant 11,433,099 - Schimmack , et al. September 6, 2 | 2022-09-06 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 11,433,124 - Mahr , et al. September 6, 2 | 2022-09-06 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220273783 - MAHR; Andrea ; et al. | 2022-09-01 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,427,622 - Song , et al. August 30, 2 | 2022-08-30 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220265793 - MAHR; Andrea ; et al. | 2022-08-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220265794 - MAHR; Andrea ; et al. | 2022-08-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220265795 - MAHR; Andrea ; et al. | 2022-08-25 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20220265764 - FRITSCHE; Jens ; et al. | 2022-08-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220267392 - SONG; Colette ; et al. | 2022-08-25 |
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220267408 - SCHUSTER; Heiko ; et al. | 2022-08-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220267391 - SONG; Colette ; et al. | 2022-08-25 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220257738 - MAHR; Andrea ; et al. | 2022-08-18 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220257739 - WEINSCHENK; Toni ; et al. | 2022-08-18 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220257736 - MAHR; Andrea ; et al. | 2022-08-18 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,414,471 - Song , et al. August 16, 2 | 2022-08-16 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,414,470 - Song , et al. August 16, 2 | 2022-08-16 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,414,472 - Song , et al. August 16, 2 | 2022-08-16 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20220249635 - MAHR; Andrea ; et al. | 2022-08-11 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220249633 - MAHR; Andrea ; et al. | 2022-08-11 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220249632 - MAHR; Andrea ; et al. | 2022-08-11 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220249630 - MAHR; Andrea ; et al. | 2022-08-11 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,407,808 - Mahr , et al. August 9, 2 | 2022-08-09 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,407,798 - Song , et al. August 9, 2 | 2022-08-09 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,407,809 - Mahr , et al. August 9, 2 | 2022-08-09 |
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
Grant 11,406,693 - Weinschenk , et al. August 9, 2 | 2022-08-09 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,407,807 - Mahr , et al. August 9, 2 | 2022-08-09 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,407,810 - Mahr , et al. August 9, 2 | 2022-08-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Small Cell Lung Cancer And Other Cancers
App 20220242925 - MAHR; Andrea ; et al. | 2022-08-04 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 11,401,310 - Mahr , et al. August 2, 2 | 2022-08-02 |
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
Grant 11,401,319 - Mahr , et al. August 2, 2 | 2022-08-02 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220233663 - MAHR; Andrea ; et al. | 2022-07-28 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220233664 - MAHR; Andrea ; et al. | 2022-07-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220235107 - SONG; Colette ; et al. | 2022-07-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Cll And Other Cancers
App 20220226450 - MAHR; Andrea ; et al. | 2022-07-21 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220226452 - MAHR; Andrea ; et al. | 2022-07-21 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220226451 - MAHR; Andrea ; et al. | 2022-07-21 |
Uterine cancer treatments
Grant 11,390,660 - Mahr , et al. July 19, 2 | 2022-07-19 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 11,384,128 - Mahr , et al. July 12, 2 | 2022-07-12 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 11,384,129 - Mahr , et al. July 12, 2 | 2022-07-12 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 11,384,127 - Mahr , et al. July 12, 2 | 2022-07-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20220211833 - MAHR; Andrea ; et al. | 2022-07-07 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220213168 - MAHR; Andrea ; et al. | 2022-07-07 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,376,281 - Schuster , et al. July 5, 2 | 2022-07-05 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,370,817 - Song , et al. June 28, 2 | 2022-06-28 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,369,636 - Schuster , et al. June 28, 2 | 2022-06-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20220193212 - MAHR; Andrea ; et al. | 2022-06-23 |
Immunotherapy Against Several Tumors Including Lung Cancer
App 20220194984 - WEINSCHENK; Toni ; et al. | 2022-06-23 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,365,234 - Mahr , et al. June 21, 2 | 2022-06-21 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,365,235 - Mahr , et al. June 21, 2 | 2022-06-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20220184194 - MAHR; Andrea ; et al. | 2022-06-16 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20220184193 - MAHR; Andrea ; et al. | 2022-06-16 |
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
Grant 11,359,003 - Mahr , et al. June 14, 2 | 2022-06-14 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,357,797 - Schuster , et al. June 14, 2 | 2022-06-14 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220175898 - MAHR; Andrea ; et al. | 2022-06-09 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,352,401 - Song , et al. June 7, 2 | 2022-06-07 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220169692 - SONG; Colette ; et al. | 2022-06-02 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220169691 - SONG; Colette ; et al. | 2022-06-02 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220162277 - SONG; Colette ; et al. | 2022-05-26 |
Peptides And T Cells For Use In Immunotherapeutic Treatment Of Various Cancers
App 20220160851 - MAHR; Andrea ; et al. | 2022-05-26 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220152175 - MAHR; Andrea ; et al. | 2022-05-19 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220153796 - SONG; Colette ; et al. | 2022-05-19 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220152171 - MAHR; Andrea ; et al. | 2022-05-19 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 11,332,512 - Mahr , et al. May 17, 2 | 2022-05-17 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220143164 - MAHR; Andrea ; et al. | 2022-05-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220143091 - SONG; Colette ; et al. | 2022-05-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220143163 - MAHR; Andrea ; et al. | 2022-05-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220143162 - MAHR; Andrea ; et al. | 2022-05-12 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 11,324,812 - Mahr , et al. May 10, 2 | 2022-05-10 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220135636 - SONG; Colette ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220135648 - MAHR; Andrea ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220135646 - MAHR; Andrea ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220135647 - MAHR; Andrea ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220135635 - MAHR; Andrea ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220133870 - MAHR; Andrea ; et al. | 2022-05-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20220125902 - MAHR; Andrea ; et al. | 2022-04-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220127320 - SONG; Colette ; et al. | 2022-04-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220119487 - MAHR; Andrea ; et al. | 2022-04-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220119484 - MAHR; Andrea ; et al. | 2022-04-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220119485 - MAHR; Andrea ; et al. | 2022-04-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220119486 - MAHR; Andrea ; et al. | 2022-04-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220119470 - MAHR; Andrea ; et al. | 2022-04-21 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220118071 - WEINSCHENK; Toni ; et al. | 2022-04-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220112253 - MAHR; Andrea ; et al. | 2022-04-14 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220112266 - MAHR; Andrea ; et al. | 2022-04-14 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220112254 - SONG; Colette ; et al. | 2022-04-14 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 11,298,404 - Fritsche , et al. April 12, 2 | 2022-04-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220106379 - MAHR; Andrea ; et al. | 2022-04-07 |
Novel Peptides And Combination Of Peptides As Targets Or Active Ingredients For Use In Immunotherapy Against Aml And Other Cancers
App 20220105165 - MAHR; Andrea ; et al. | 2022-04-07 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220106380 - MAHR; Andrea ; et al. | 2022-04-07 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,292,821 - Song , et al. April 5, 2 | 2022-04-05 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220098275 - MAHR; Andrea ; et al. | 2022-03-31 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220098276 - MAHR; Andrea ; et al. | 2022-03-31 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20220098277 - MAHR; Andrea ; et al. | 2022-03-31 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,279,741 - Song , et al. March 22, 2 | 2022-03-22 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,279,740 - Song , et al. March 22, 2 | 2022-03-22 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 11,273,200 - Fritsche , et al. March 15, 2 | 2022-03-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220064240 - MAHR; Andrea ; et al. | 2022-03-03 |
Immunotherapy Against Several Tumors Including Lung Cancer
App 20220064220 - WEINSCHENK; Toni ; et al. | 2022-03-03 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220064241 - MAHR; Andrea ; et al. | 2022-03-03 |
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
Grant 11,260,115 - Mahr , et al. March 1, 2 | 2022-03-01 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,261,224 - Song , et al. March 1, 2 | 2022-03-01 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220056103 - MAHR; Andrea ; et al. | 2022-02-24 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220054613 - WEINSCHENK; Toni ; et al. | 2022-02-24 |
Novel Peptides And Combination Of Peptides And Scaffolds For Use In Immunotherapy Against Renal Cell Carcinoma (rcc) And Other Cancers
App 20220054612 - MAHR; Andrea ; et al. | 2022-02-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20220048964 - MAHR; Andrea ; et al. | 2022-02-17 |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,246,917 - Song , et al. February 15, 2 | 2022-02-15 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220041690 - MAHR; Andrea ; et al. | 2022-02-10 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20220040277 - MAHR; Andrea ; et al. | 2022-02-10 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20220040259 - FRITSCHE; Jens ; et al. | 2022-02-10 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220041689 - MAHR; Andrea ; et al. | 2022-02-10 |
Novel Peptides And Combination Of Peptides And Scaffolds For Use In Immunotherapy Against Renal Cell Carcinoma (rcc) And Other Cancers
App 20220040278 - MAHR; Andrea ; et al. | 2022-02-10 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220031824 - WEINSCHENK; Toni ; et al. | 2022-02-03 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220033469 - MAHR; Andrea ; et al. | 2022-02-03 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 11,235,042 - Mahr , et al. February 1, 2 | 2022-02-01 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 11,235,041 - Mahr , et al. February 1, 2 | 2022-02-01 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220023404 - WEINSCHENK; Toni ; et al. | 2022-01-27 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220023403 - WEINSCHENK; Toni ; et al. | 2022-01-27 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 11,230,581 - Mahr , et al. January 25, 2 | 2022-01-25 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20220016207 - FRITSCHE; Jens ; et al. | 2022-01-20 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20220016227 - WEINSCHENK; Toni ; et al. | 2022-01-20 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220017595 - MAHR; Andrea ; et al. | 2022-01-20 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20220016209 - FRITSCHE; Jens ; et al. | 2022-01-20 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220017598 - MAHR; Andrea ; et al. | 2022-01-20 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 11,224,644 - Mahr , et al. January 18, 2 | 2022-01-18 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20220008506 - FRITSCHE; Jens ; et al. | 2022-01-13 |
Immunotherapy With B*08 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220008471 - SCHIMMACK; Gisela ; et al. | 2022-01-13 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220009995 - MAHR; Andrea ; et al. | 2022-01-13 |
Immunotherapy With B*08 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220008472 - SCHIMMACK; Gisela ; et al. | 2022-01-13 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220009982 - SCHUSTER; Heiko ; et al. | 2022-01-13 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20220009983 - SONG; Colette ; et al. | 2022-01-13 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220002366 - SCHUSTER; Heiko ; et al. | 2022-01-06 |
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220002374 - SCHUSTER; Heiko ; et al. | 2022-01-06 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20220000922 - SCHUSTER; Heiko ; et al. | 2022-01-06 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20220002378 - MAHR; Andrea ; et al. | 2022-01-06 |
Peptides for use in immunotherapy against cancers
Grant 11,214,604 - Song , et al. January 4, 2 | 2022-01-04 |
Novel Peptides, Combination Of Peptides As Targets And For Use In Immunotherapy Against Gallbladder Cancer And Cholangiocarcinoma And Other Cancers
App 20210403531 - MAHR; Andrea ; et al. | 2021-12-30 |
Novel Peptides And Scaffolds For Use In Immunotherapy Against Head And Neck Squamous Cell Carcinoma And Other Cancers
App 20210401888 - MAHR; Andrea ; et al. | 2021-12-30 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210401892 - SCHUSTER; Heiko ; et al. | 2021-12-30 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210403530 - MAHR; Andrea ; et al. | 2021-12-30 |
Peptides for use in immunotherapy against cancers
Grant 11,208,449 - Song , et al. December 28, 2 | 2021-12-28 |
Immunotherapy against several tumors including neuronal and brain tumors
Grant 11,208,434 - Weinschenk , et al. December 28, 2 | 2021-12-28 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,208,448 - Song , et al. December 28, 2 | 2021-12-28 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210395338 - MAHR; Andrea ; et al. | 2021-12-23 |
Personalized Immunotherapy Against Several Neuronal And Brain Tumors
App 20210393754 - KUTTRUFF-COQUI; Sabrina ; et al. | 2021-12-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210395336 - MAHR; Andrea ; et al. | 2021-12-23 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210395335 - MAHR; Andrea ; et al. | 2021-12-23 |
Novel Peptides And Combination Of Peptides And Scaffolds For Use In Immunotherapy Against Renal Cell Carcinoma (rcc) And Other Cancers
App 20210393756 - MAHR; Andrea ; et al. | 2021-12-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210395334 - MAHR; Andrea ; et al. | 2021-12-23 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210395337 - MAHR; Andrea ; et al. | 2021-12-23 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,197,892 - Schuster , et al. December 14, 2 | 2021-12-14 |
Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
App 20210380662 - MAHR; Andrea ; et al. | 2021-12-09 |
Personalized Immunotherapy Against Several Neuronal And Brain Tumors
App 20210369826 - KUTTRUFF-COQUI; Sabrina ; et al. | 2021-12-02 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210363211 - SONG; Colette ; et al. | 2021-11-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210363210 - SONG; Colette ; et al. | 2021-11-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210363209 - SONG; Colette ; et al. | 2021-11-25 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210363208 - SONG; Colette ; et al. | 2021-11-25 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,179,418 - Schuster , et al. November 23, 2 | 2021-11-23 |
Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
Grant 11,180,532 - Mahr , et al. November 23, 2 | 2021-11-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210353728 - MAHR; Andrea ; et al. | 2021-11-18 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210346481 - MAHR; Andrea ; et al. | 2021-11-11 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210346466 - FRITSCHE; Jens ; et al. | 2021-11-11 |
Novel Immunotherapy Against Several Tumors Including Neuronal And Brain Tumors
App 20210347822 - WEINSCHENK; Toni ; et al. | 2021-11-11 |
Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210346465 - FRITSCHE; Jens ; et al. | 2021-11-11 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,168,122 - Song , et al. November 9, 2 | 2021-11-09 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210338734 - SCHUSTER; Heiko ; et al. | 2021-11-04 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210338735 - SCHUSTER; Heiko ; et al. | 2021-11-04 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210340204 - SONG; Colette ; et al. | 2021-11-04 |
Peptides For Use In Immunotherapy Against Cancers
App 20210340202 - SONG; Colette ; et al. | 2021-11-04 |
Peptides For Use In Immunotherapy Against Cancers
App 20210340203 - SONG; Colette ; et al. | 2021-11-04 |
Immunotherapy against several tumors including lung cancer
Grant 11,161,877 - Weinschenk , et al. November 2, 2 | 2021-11-02 |
Immunotherapy against several tumors including lung cancer
Grant 11,161,878 - Weinschenk , et al. November 2, 2 | 2021-11-02 |
Immunotherapy against several tumors, such as lung cancer, including NSCLC
Grant 11,161,880 - Weinschenk , et al. November 2, 2 | 2021-11-02 |
Immunotherapy against several tumors, such as lung cancer, including NSCLC
Grant 11,161,879 - Weinschenk , et al. November 2, 2 | 2021-11-02 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210330772 - SONG; Colette ; et al. | 2021-10-28 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210330771 - SONG; Colette ; et al. | 2021-10-28 |
Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210330743 - FRITSCHE; Jens ; et al. | 2021-10-28 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210330708 - SCHUSTER; Heiko ; et al. | 2021-10-28 |
Relaxin1 derived peptides for use in immunotherapy
Grant 11,155,597 - Mahr , et al. October 26, 2 | 2021-10-26 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,154,576 - Schuster , et al. October 26, 2 | 2021-10-26 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,155,590 - Song , et al. October 26, 2 | 2021-10-26 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Pancreatic Cancer And Other Cancers
App 20210322527 - WEINSCHENK; Toni ; et al. | 2021-10-21 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,147,838 - Schuster , et al. October 19, 2 | 2021-10-19 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,147,839 - Schuster , et al. October 19, 2 | 2021-10-19 |
Novel Peptides And Combination Of Peptides And Scaffolds Thereof For Use In Immunotherapy Against Colorectal Carcinoma (crc) And Other Cancers
App 20210317175 - SCHOOR; Oliver ; et al. | 2021-10-14 |
Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers
Grant 11,141,437 - Schuster , et al. October 12, 2 | 2021-10-12 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 11,142,556 - Schuster , et al. October 12, 2 | 2021-10-12 |
Uterine Cancer Treatments
App 20210309715 - MAHR; Andrea ; et al. | 2021-10-07 |
Immunotherapy against several tumors including neuronal and brain tumors
Grant 11,136,352 - Weinschenk , et al. October 5, 2 | 2021-10-05 |
Uterine Cancer Treatments
App 20210300968 - MAHR; Andrea ; et al. | 2021-09-30 |
Peptides, Combination Of Peptides, And Cell Based Medicaments For Use In Immunotherapy Against Urinary Bladder Cancer And Other Cancers
App 20210292365 - MAHR; Andrea ; et al. | 2021-09-23 |
Peptides, Combination Of Peptides, And Cell Based Medicaments For Use In Immunotherapy Against Urinary Bladder Cancer And Other Cancers
App 20210292367 - MAHR; Andrea ; et al. | 2021-09-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Breast Cancer And Other Cancers
App 20210290743 - MAHR; Andrea ; et al. | 2021-09-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210290745 - MAHR; Andrea ; et al. | 2021-09-23 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210290744 - MAHR; Andrea ; et al. | 2021-09-23 |
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
Grant 11,123,370 - Mahr , et al. September 21, 2 | 2021-09-21 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Small Cell Lung Cancer And Other Cancers
App 20210284704 - MAHR; Andrea ; et al. | 2021-09-16 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20210283230 - MAHR; Andrea ; et al. | 2021-09-16 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210283231 - MAHR; Andrea ; et al. | 2021-09-16 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,117,941 - Song , et al. September 14, 2 | 2021-09-14 |
Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
Grant 11,117,951 - Mahr , et al. September 14, 2 | 2021-09-14 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 11,116,826 - Weinschenk , et al. September 14, 2 | 2021-09-14 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Cancers
App 20210275656 - MAHR; Andrea ; et al. | 2021-09-09 |
Peptides And Combination Of Peptides And Scaffolds For Use In Immunotherapy Against Renal Cell Carcinoma (rcc) And Other Cancers
App 20210275652 - MAHR; Andrea ; et al. | 2021-09-09 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20210275653 - MAHR; Andrea ; et al. | 2021-09-09 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210275634 - FRITSCHE; Jens ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20210275654 - MAHR; Andrea ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20210275655 - MAHR; Andrea ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20210277081 - MAHR; Andrea ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20210277087 - MAHR; Andrea ; et al. | 2021-09-09 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210277080 - SONG; Colette ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20210277086 - MAHR; Andrea ; et al. | 2021-09-09 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20210277088 - MAHR; Andrea ; et al. | 2021-09-09 |
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
Grant 11,111,280 - Mahr , et al. September 7, 2 | 2021-09-07 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,111,281 - Song , et al. September 7, 2 | 2021-09-07 |
Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20210268089 - WEINSCHENK; Toni ; et al. | 2021-09-02 |
Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210268063 - FRITSCHE; Jens ; et al. | 2021-09-02 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,103,535 - Schuster , et al. August 31, 2 | 2021-08-31 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210260160 - FRITSCHE; Jens ; et al. | 2021-08-26 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210260120 - SCHUSTER; Heiko ; et al. | 2021-08-26 |
Novel Immunotherapy Against Several Tumors Including Neuronal And Brain Tumors
App 20210261614 - WEINSCHENK; Toni ; et al. | 2021-08-26 |
Novel Peptides And Scaffolds For Use In Immunotherapy Against Head And Neck Squamous Cell Carcinoma And Other Cancers
App 20210252061 - MAHR; Andrea ; et al. | 2021-08-19 |
Novel Immunotherapy Against Several Tumors Including Neuronal And Brain Tumors
App 20210253637 - WEINSCHENK; Toni ; et al. | 2021-08-19 |
Immunotherapy Against Several Tumors Including Lung Cancer
App 20210253640 - WEINSCHENK; Toni ; et al. | 2021-08-19 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210246181 - SONG; Colette ; et al. | 2021-08-12 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210244765 - SCHUSTER; Heiko ; et al. | 2021-08-12 |
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
Grant 11,083,784 - Mahr , et al. August 10, 2 | 2021-08-10 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20210238243 - SCHUSTER; Heiko ; et al. | 2021-08-05 |
Novel Immunotherapy Against Several Tumors Including Neuronal And Brain Tumors
App 20210238227 - WEINSCHENK; Toni ; et al. | 2021-08-05 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,077,142 - Schuster , et al. August 3, 2 | 2021-08-03 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 11,077,171 - Fritsche , et al. August 3, 2 | 2021-08-03 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210230240 - SONG; Colette ; et al. | 2021-07-29 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Pancreatic Cancer And Other Cancers
App 20210228698 - WEINSCHENK; Toni ; et al. | 2021-07-29 |
Personalized Immunotherapy Against Several Neuronal And Brain Tumors
App 20210228697 - KUTTRUFF-COQUI; Sabrina ; et al. | 2021-07-29 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 11,071,773 - Mahr , et al. July 27, 2 | 2021-07-27 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,065,279 - Schuster , et al. July 20, 2 | 2021-07-20 |
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
Grant 11,065,315 - Mahr , et al. July 20, 2 | 2021-07-20 |
Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers
Grant 11,065,316 - Mahr , et al. July 20, 2 | 2021-07-20 |
Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
Grant 11,065,314 - Mahr , et al. July 20, 2 | 2021-07-20 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210213064 - SCHUSTER; Heiko ; et al. | 2021-07-15 |
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
Grant 11,058,754 - Mahr , et al. July 13, 2 | 2021-07-13 |
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
Grant 11,058,726 - Mahr , et al. July 13, 2 | 2021-07-13 |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,058,755 - Song , et al. July 13, 2 | 2021-07-13 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,058,727 - Schuster , et al. July 13, 2 | 2021-07-13 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,052,114 - Schuster , et al. July 6, 2 | 2021-07-06 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,052,113 - Schuster , et al. July 6, 2 | 2021-07-06 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210188943 - MAHR; Andrea ; et al. | 2021-06-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210188944 - MAHR; Andrea ; et al. | 2021-06-24 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,040,069 - Schuster , et al. June 22, 2 | 2021-06-22 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20210179691 - MAHR; Andrea ; et al. | 2021-06-17 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,033,585 - Schuster , et al. June 15, 2 | 2021-06-15 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,033,583 - Schuster , et al. June 15, 2 | 2021-06-15 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 11,027,002 - Mahr , et al. June 8, 2 | 2021-06-08 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,026,977 - Schuster , et al. June 8, 2 | 2021-06-08 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20210162004 - FRITSCHE; Jens ; et al. | 2021-06-03 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,020,434 - Schuster , et al. June 1, 2 | 2021-06-01 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,020,433 - Schuster , et al. June 1, 2 | 2021-06-01 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Nhl And Other Cancers
App 20210154284 - SCHOOR; Oliver ; et al. | 2021-05-27 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,766 - Schuster , et al. May 25, 2 | 2021-05-25 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,014,972 - Song , et al. May 25, 2 | 2021-05-25 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,769 - Schuster , et al. May 25, 2 | 2021-05-25 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,768 - Schuster , et al. May 25, 2 | 2021-05-25 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145887 - SCHUSTER; Heiko ; et al. | 2021-05-20 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20210145952 - MAHR; Andrea ; et al. | 2021-05-20 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145886 - SCHUSTER; Heiko ; et al. | 2021-05-20 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145888 - SCHUSTER; Heiko ; et al. | 2021-05-20 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 11,007,257 - Weinschenk , et al. May 18, 2 | 2021-05-18 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 11,007,258 - Weinschenk , et al. May 18, 2 | 2021-05-18 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210137985 - SCHUSTER; Heiko ; et al. | 2021-05-13 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210137986 - SCHUSTER; Heiko ; et al. | 2021-05-13 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210138052 - SONG; Colette ; et al. | 2021-05-13 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 11,001,616 - Song , et al. May 11, 2 | 2021-05-11 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 11,001,617 - Schuster , et al. May 11, 2 | 2021-05-11 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210128707 - SONG; Colette ; et al. | 2021-05-06 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210128708 - SONG; Colette ; et al. | 2021-05-06 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,993,962 - Schuster , et al. May 4, 2 | 2021-05-04 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,993,964 - Schuster , et al. May 4, 2 | 2021-05-04 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210113619 - SCHUSTER; Heiko ; et al. | 2021-04-22 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210100845 - SCHUSTER; Heiko ; et al. | 2021-04-08 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 10,967,053 - Mahr , et al. April 6, 2 | 2021-04-06 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210094992 - SONG; Colette ; et al. | 2021-04-01 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20210093702 - MAHR; Andrea ; et al. | 2021-04-01 |
Novel Peptides And Combination Of Peptides As Targets Or Active Ingredients For Use In Immunotherapy Against Aml And Other Cancers
App 20210085767 - MAHR; Andrea ; et al. | 2021-03-25 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,954,281 - Schuster , et al. March 23, 2 | 2021-03-23 |
*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,946,081 - Song , et al. March 16, 2 | 2021-03-16 |
Personalized immunotherapy against several neuronal and brain tumors
Grant 10,946,064 - Kuttruff-Coqui , et al. March 16, 2 | 2021-03-16 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,947,286 - Song , et al. March 16, 2 | 2021-03-16 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,947,293 - Mahr , et al. March 16, 2 | 2021-03-16 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,947,294 - Mahr , et al. March 16, 2 | 2021-03-16 |
Novel Peptides And Scaffolds For Use In Immunotherapy Against Head And Neck Squamous Cell Carcinoma And Other Cancers
App 20210069250 - MAHR; ANDREA ; et al. | 2021-03-11 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210069251 - SCHUSTER; Heiko ; et al. | 2021-03-11 |
Immunotherapy against several tumors including neuronal and brain tumors
Grant 10,941,181 - Weinschenk , et al. March 9, 2 | 2021-03-09 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060077 - SCHUSTER; Heiko ; et al. | 2021-03-04 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060074 - SCHUSTER; Heiko ; et al. | 2021-03-04 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060078 - SCHUSTER; Heiko ; et al. | 2021-03-04 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 10,933,118 - Fritsche , et al. March 2, 2 | 2021-03-02 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 10,934,333 - Mahr , et al. March 2, 2 | 2021-03-02 |
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
Grant 10,933,125 - Schoor , et al. March 2, 2 | 2021-03-02 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,934,338 - Mahr , et al. March 2, 2 | 2021-03-02 |
Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
Grant 10,934,339 - Mahr , et al. March 2, 2 | 2021-03-02 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052652 - SCHUSTER; Heiko ; et al. | 2021-02-25 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052651 - SCHUSTER; Heiko ; et al. | 2021-02-25 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052654 - SCHUSTER; Heiko ; et al. | 2021-02-25 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052653 - SCHUSTER; Heiko ; et al. | 2021-02-25 |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,925,947 - Song , et al. February 23, 2 | 2021-02-23 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 10,925,948 - Mahr , et al. February 23, 2 | 2021-02-23 |
Method For The Characterization Of Peptide:mhc Binding Polypeptides
App 20210048442 - SCHUSTER; Heiko ; et al. | 2021-02-18 |
Immunotherapy against several tumors including neuronal and brain tumors
Grant 10,919,931 - Weinschenk , et al. February 16, 2 | 2021-02-16 |
Methods For Peptide Mass Spectrometry Fragmentation Prediction
App 20210041454A1 - | 2021-02-11 |
Novel Peptides And Combination Of Peptides And Scaffolds For Use In Immunotherapy Against Renal Cell Carcinoma (rcc) And Other Cancers
App 20210030854A1 - | 2021-02-04 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,905,719 - Schuster , et al. February 2, 2 | 2021-02-02 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,905,720 - Schuster , et al. February 2, 2 | 2021-02-02 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 10,905,741 - Fritsche , et al. February 2, 2 | 2021-02-02 |
Immunotherapy against several tumors including neuronal and brain tumors
Grant 10,906,936 - Weinschenk , et al. February 2, 2 | 2021-02-02 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Nhl And Other Cancers
App 20210023190A1 - | 2021-01-28 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20210024609A1 - | 2021-01-28 |
Anti-wt1/hla-specific Antibodies
App 20210024635A1 - | 2021-01-28 |
Immunotherapy against several tumors including gastrointestinal and gastric cancer
Grant 10,898,546 - Fritsche , et al. January 26, 2 | 2021-01-26 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,899,810 - Song , et al. January 26, 2 | 2021-01-26 |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,899,811 - Song , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,898,519 - Schuster , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,899,808 - Song , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,898,518 - Schuster , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,899,807 - Song , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
Grant 10,899,806 - Mahr , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 10,898,561 - Weinschenk , et al. January 26, 2 | 2021-01-26 |
Method of treating with a peptide
Grant 10,898,557 - Mahr , et al. January 26, 2 | 2021-01-26 |
Method of treating with a peptide
Grant 10,898,558 - Mahr , et al. January 26, 2 | 2021-01-26 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,814 - Schuster , et al. January 26, 2 | 2021-01-26 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,812 - Schuster , et al. January 26, 2 | 2021-01-26 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,813 - Schuster , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 10,898,560 - Mahr , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
Grant 10,898,559 - Mahr , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,899,809 - Song , et al. January 26, 2 | 2021-01-26 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,894,064 - Schuster , et al. January 19, 2 | 2021-01-19 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,583 - Schuster , et al. January 12, 2 | 2021-01-12 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,582 - Schuster , et al. January 12, 2 | 2021-01-12 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,584 - Schuster , et al. January 12, 2 | 2021-01-12 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,585 - Schuster , et al. January 12, 2 | 2021-01-12 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,586 - Schuster , et al. January 12, 2 | 2021-01-12 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20210002340A1 - | 2021-01-07 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,874,696 - Schuster , et al. December 29, 2 | 2020-12-29 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,874,695 - Schuster , et al. December 29, 2 | 2020-12-29 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200399334A1 - | 2020-12-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20200397880A1 - | 2020-12-24 |
Method Of Treating With A Peptide
App 20200397879A1 - | 2020-12-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20200397878A1 - | 2020-12-24 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,890 - Schuster , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,895 - Schuster , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,891 - Schuster , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,892 - Schuster , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,894 - Schuster , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,893 - Schuster , et al. December 22, 2 | 2020-12-22 |
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,870,685 - Schuster , et al. December 22, 2 | 2020-12-22 |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,869,917 - Song , et al. December 22, 2 | 2020-12-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,896 - Schuster , et al. December 22, 2 | 2020-12-22 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200392194A1 - | 2020-12-17 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc And Other Cancers
App 20200384093A1 - | 2020-12-10 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (hcc) And Other Cancers
App 20200376103A1 - | 2020-12-03 |
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
Grant 10,842,817 - Mahr , et al. November 24, 2 | 2020-11-24 |
Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
Grant 10,835,586 - Mahr , et al. November 17, 2 | 2020-11-17 |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
Grant 10,835,587 - Mahr , et al. November 17, 2 | 2020-11-17 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,836,806 - Song , et al. November 17, 2 | 2020-11-17 |
Anti-WT1/HLA-specific antibodies
Grant 10,836,829 - Mahr , et al. November 17, 2 | 2020-11-17 |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
Grant 10,835,588 - Mahr , et al. November 17, 2 | 2020-11-17 |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,828,357 - Song , et al. November 10, 2 | 2020-11-10 |
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
Grant 10,829,537 - Mahr , et al. November 10, 2 | 2020-11-10 |
Novel Immunotherapy Against Neuronal And Brain Tumors
App 20200345777A1 - | 2020-11-05 |
Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
Grant 10,822,390 - Mahr , et al. November 3, 2 | 2020-11-03 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Pancreatic Cancer And Other Cancers
App 20200338175A1 - | 2020-10-29 |
Peptides, Combination Of Peptides, And Cell Based Medicaments For Use In Immunotherapy Against Urinary Bladder Cancer And Other Cancers
App 20200339630A1 - | 2020-10-29 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20200338126A1 - | 2020-10-29 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339646A1 - | 2020-10-29 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339645A1 - | 2020-10-29 |
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339644A1 - | 2020-10-29 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,813,953 - Schuster , et al. October 27, 2 | 2020-10-27 |
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
Grant 10,813,986 - Schoor , et al. October 27, 2 | 2020-10-27 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20200330552A1 - | 2020-10-22 |
Method Of Treating With A Peptide
App 20200323968A1 - | 2020-10-15 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200323970A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides As Targets Or Active Ingredients For Use In Immunotherapy Against Aml And Other Cancers
App 20200323967A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Prostate Cancer And Other Cancers
App 20200323969A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323916A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323915A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20200325191A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323918A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323919A1 - | 2020-10-15 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325195A1 - | 2020-10-15 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325199A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20200325206A1 - | 2020-10-15 |
Novel Peptides, Combination Of Peptides As Targets And For Use In Immunotherapy Against Gallbladder Cancer And Cholangiocarcinoma And Other Cancers
App 20200325207A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323914A1 - | 2020-10-15 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325198A1 - | 2020-10-15 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325197A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20200325193A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20200325194A1 - | 2020-10-15 |
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325196A1 - | 2020-10-15 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20200325192A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323913A1 - | 2020-10-15 |
Novel Peptides And Scaffolds For Use In Immunotherapy Against Head And Neck Squamous Cell Carcinoma And Other Cancers
App 20200323912A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323906A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323909A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323907A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323910A1 - | 2020-10-15 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323911A1 - | 2020-10-15 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,799,537 - Schuster , et al. October 13, 2 | 2020-10-13 |
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
Grant 10,799,569 - Mahr , et al. October 13, 2 | 2020-10-13 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,800,823 - Song , et al. October 13, 2 | 2020-10-13 |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
Grant 10,799,570 - Mahr , et al. October 13, 2 | 2020-10-13 |
Novel Peptides And Combination Of Peptides As Targets Or Active Ingredients For Use In Immunotherapy Against Aml And Other Cancers
App 20200316182A1 - | 2020-10-08 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Pancreatic Cancer And Other Cancers
App 20200316183A1 - | 2020-10-08 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,792,307 - Schuster , et al. October 6, 2 | 2020-10-06 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,792,308 - Schuster , et al. October 6, 2 | 2020-10-06 |
Immunotherapy against several tumors, such as lung cancer, including NSCLC
Grant 10,793,602 - Weinschenk , et al. October 6, 2 | 2020-10-06 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 10,792,350 - Weinschenk , et al. October 6, 2 | 2020-10-06 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306305A1 - | 2020-10-01 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306308A1 - | 2020-10-01 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Various Tumors
App 20200308250A1 - | 2020-10-01 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306311A1 - | 2020-10-01 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297771A1 - | 2020-09-24 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297770A1 - | 2020-09-24 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297772A1 - | 2020-09-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Nhl And Other Cancers
App 20200297831A1 - | 2020-09-24 |
Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer
App 20200297801A1 - | 2020-09-24 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Lung Cancer, Including Nsclc, Sclc And Other Cancers
App 20200299346A1 - | 2020-09-24 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,122 - Schuster , et al. Sept | 2020-09-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,123 - Schuster , et al. Sept | 2020-09-22 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,124 - Schuster , et al. Sept | 2020-09-22 |
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
Grant 10,780,125 - Mahr , et al. Sept | 2020-09-22 |
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200289632A1 - | 2020-09-17 |
Method Of Treating With A Peptide
App 20200289631A1 - | 2020-09-17 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers
App 20200291084A1 - | 2020-09-17 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Esophageal Cancer And Other Cancers
App 20200291088A1 - | 2020-09-17 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,772,915 - Schuster , et al. September 15, 2 | 2020-09-15 |
Peptides and combination of peptides for use in immunotherapy against various cancers
Grant 10,765,730 - Mahr , et al. Sep | 2020-09-08 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,766,944 - Mahr , et al. Sep | 2020-09-08 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268798A1 - | 2020-08-27 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268799A1 - | 2020-08-27 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Breast Cancer And Other Cancers
App 20200268863A1 - | 2020-08-27 |
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268800A1 - | 2020-08-27 |
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Pancreatic Cancer And Other Cancers
App 20200268861A1 - | 2020-08-27 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,751,369 - Schuster , et al. A | 2020-08-25 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,745,460 - Mahr , et al. A | 2020-08-18 |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Grant 10,738,094 - Mahr , et al. A | 2020-08-11 |
Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
Grant 10,729,755 - Weinschenk , et al. | 2020-08-04 |
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
Grant 10,722,536 - Mahr , et al. | 2020-07-28 |
Peptides and combination of peptides for use in immunotherapy against various tumors
Grant 10,723,781 - Mahr , et al. | 2020-07-28 |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
Grant 10,722,565 - Mahr , et al. | 2020-07-28 |
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
Grant 10,722,566 - Mahr , et al. | 2020-07-28 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,736 - Schuster , et al. | 2020-07-14 |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
Grant 10,711,048 - Song , et al. | 2020-07-14 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,738 - Schuster , et al. | 2020-07-14 |
Immunotherapy against neuronal and brain tumors
Grant 10,709,735 - Weinschenk , et al. | 2020-07-14 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,737 - Schuster , et al. | 2020-07-14 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,702,553 - Schuster , et al. | 2020-07-07 |
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
Grant 10,703,795 - Mahr , et al. | 2020-07-07 |
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
Grant 10,702,592 - Schoor , et al. | 2020-07-07 |
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
Grant 10,702,593 - Schoor , et al. | 2020-07-07 |
Method of treating with a peptide
Grant 10,695,411 - Mahr , et al. | 2020-06-30 |
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,375 - Schuster , et al. | 2020-06-30 |
| 